Research advances in prostate cancer stem cells and radiotherapy resistance of castration-resistant prostate cancer
10.3760/cma.j.issn.1004-4221.2017.11.023
- VernacularTitle:前列腺癌干细胞与去势抵抗性前列腺癌放射性耐受的研究进展
- Author:
Yifei ZHU
1
;
Hao ZENG
Author Information
1. 新疆自治区人民医院泌尿中心
- Keywords:
Castration Resistant Prostate Cancer;
Cancer stem cell;
Prostate cancer stem cell;
Micro-ribonucleic acid
- From:
Chinese Journal of Radiation Oncology
2017;26(11):1347-1349
- CountryChina
- Language:Chinese
-
Abstract:
Prostate cancer tends to progress to castration-resistant prostate cancer within 24 months after castration. For the management of castration-resistant prostate cancer, the biggest challenge is therapeutic resistance which includes radiotherapy resistance. Relevant studies suggest that the radiotherapy resistance of castration-resistant prostate cancer is associated with prostate cancer stem cells and miRNA related to prostate cancer stem cells. This article reviews the research advances in the radiotherapy resistance of castration-resistant prostate cancer in terms of the possible mechanisms of castration-resistant prostate cancer,prostate cancer stem cells,and miRNA related to prostate cancer stem cells.